Terconazole and Bone density decreased - a phase IV clinical study of FDA data

Summary:

Bone density decreased is reported as a side effect among people who take Terconazole (terconazole), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Atripla, and have Hiv infection.

The phase IV clinical study analyzes which people have Bone density decreased when taking Terconazole. It is created by eHealthMe based on reports of 987 people who have side effects when taking Terconazole from the FDA, and is updated regularly.

What is Terconazole?

Terconazole has active ingredients of terconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 1,004 Terconazole users. Check the latest studies of Terconazole.

What is Bone density decreased?

Bone density decreased is found to be associated with 1,127 drugs and 945 conditions by eHealthMe. Check the latest studies of Bone density decreased.

On Jul, 14, 2026

987 people reported to have side effects when taking Terconazole.
Among them, 24 people (2.43%) have Bone density decreased.

Could Terconazole cause Bone density decreased?

Among these 24 people:

How long have people been on Terconazole when they have Bone density decreased? *

What is the gender of people who have Bone density decreased when taking Terconazole? *

female: 100 %
male: 0.0 %

What is the age of people who have Bone density decreased when taking Terconazole? *

What are other drugs people take besides Terconazole? *

What are other side effects people have besides Bone density decreased? *

Osteoporosis (bones weak and more likely to break): 19 people, 79.17%
Stress And Anxiety: 18 people, 75.00%
Pain: 17 people, 70.83%
Emotional Distress: 16 people, 66.67%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 16 people, 66.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 33.33%
Chronic Kidney Disease: 8 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 20.83%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 5 people, 20.83%
Hepatic Steatosis (fatty liver disease): 5 people, 20.83%

What are the existing conditions these people have? *

Hiv Infection: 18 people, 75.00%
High Blood Pressure: 7 people, 29.17%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 5 people, 20.83%
Viral Infection: 4 people, 16.67%
Urinary Tract Infection: 4 people, 16.67%
Fungal Infection: 4 people, 16.67%
Bacterial Infection: 4 people, 16.67%
Pain: 4 people, 16.67%
Stress And Anxiety: 2 people, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Terconazole and have Bone density decreased?

- Check whether Bone density decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Terconazole:

Terconazole (1,004 reports)

Browse all side effects of Terconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone density decreased:

Bone density decreased (1,127 drugs)

Browse all the conditions that are associated with Bone density decreased:

Bone density decreased (945 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terconazole (the active ingredients of Terconazole) and Terconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.